C.E.O
CurrentBioClonal is focused on Antibody Discovery, offering custom-tailored solutions. We empower your mAb to the extraordinary, providing Real Biobetters, a more powerful analogue of your existing mAbs as well as new proprietary discoveries.We aim to partner pharmaceutical and biotechnology companies worldwide, solving or minimizing affinity, specificity and developability problems, through our innovative technologies and in vivo platforms, RedMabs and NextMabs.Your challenge is our mission. Based on a win- win philosophy, we seek long-term agreements of co-discovery and co-development.